Docusign dived after disappointing first-quarter results broke a streak of better numbers. Wall Street is split on whether to accept the e-signature company’s view that the stumble will be limited to a single quarter.

That said, Docusign stock sells for an unchallenging valuation of only 16.6 times trailing FCF -- cheaper than that when you factor in net cash on the balance sheet. If Docusign can just find a way to goose its growth rate again, this stock could still be a buy.